The healthcare third-party logistics (3PL) market refers to the outsourcing of logistics and supply chain operations related to pharmaceuticals, medical devices, and healthcare products to specialized third-party service providers. These services include transportation, warehousing, inventory management, packaging, order fulfillment, and distribution. Healthcare 3PL providers help pharmaceutical and medical companies ensure timely and secure delivery of temperature-sensitive and high-value products while meeting strict regulatory and quality standards.
The expansion of global pharmaceutical trade is a significant driver increasing the demand for healthcare third-party logistics (3PL) services. As pharmaceutical companies extend their reach to international markets, the complexity of their supply chains grows substantially. Managing the shipment of medicines, vaccines, and biologics across borders requires specialized logistics solutions that ensure compliance with diverse regulatory requirements, temperature control, and product safety. Third-party logistics providers offer the expertise and infrastructure needed to navigate these challenges efficiently, including customs clearance, secure transportation, and real-time tracking. For instance, in March 2025, DHL Group acquired CRYOPDP from Cryoport, a supply chain logistics company, which represents a strategic move to strengthen its healthcare third-party logistics (3PL) capabilities. By enhancing specialized pharmaceutical logistics services, including temperature-controlled and secure distribution, DHL is expanding its role as a key 3PL provider in the life sciences and healthcare sector. This acquisition enables DHL to offer more comprehensive and reliable logistics solutions that meet the complex demands of healthcare products, thus supporting efficient supply chain management and ensuring the safe delivery of sensitive pharmaceuticals globally. In addition, the rise in cross-border e-commerce and direct-to-patient deliveries has heightened the need for reliable, scalable logistics services that can handle various distribution models worldwide. The globalization of pharmaceutical trade also demands agility to respond to varying market demands and supply disruptions. As a result, pharmaceutical companies increasingly rely on 3PL providers, thus driving robust growth in the healthcare third-party logistics sector.
The complex regulatory landscape significantly hampers the demand for healthcare third-party logistics (3PL) services. The healthcare industry is governed by stringent regulations related to the storage, transportation, and handling of sensitive products like pharmaceuticals, biologics, and medical devices. Compliance with diverse and constantly evolving regulations across different countries, including Good Distribution Practices (GDP), temperature control standards, and safety protocols, creates substantial challenges for 3PL providers. Navigating this regulatory complexity requires significant investments in specialized infrastructure, training, and technology, which can be costly and time-consuming. In addition, non-compliance risks include severe penalties, product recalls, and damage to reputation, making 3PL providers cautious in expanding operations. These regulatory hurdles often slow market entry and limit the flexibility of logistics providers, especially in emerging markets with less harmonized standards. Consequently, the complex regulatory environment restricts the growth potential of healthcare 3PL services despite the increasing demand for efficient and compliant supply chain solutions.
The increasing demand for end-to-end logistics solutions presents a lucrative opportunity for the healthcare third-party logistics (3PL) market. Healthcare companies are seeking comprehensive logistics providers that can manage the entire supply chain from procurement and storage to transportation and final delivery, ensuring seamless and efficient operations. End-to-end solutions help streamline complex processes, reduce costs, and improve visibility and traceability of sensitive products such as pharmaceuticals and biologics. With the rise of personalized medicine, temperature-sensitive products, and direct-to-patient distribution, healthcare providers require integrated logistics services that maintain product integrity and comply with stringent regulations. Third-party logistics providers offering these complete solutions can differentiate themselves by providing greater reliability, flexibility, and technology-driven transparency, which attracts more clients. Thus, rise in demand for end-to-end logistics solutions is expected to provide lucrative opportunities for the market.
The healthcare third-party logistics market is segmented on the basis of service type, end-user, medium of transport, and region. On the basis of service type, the market is segmented into transport service, warehouse and storage service, inventory management, clinical trial logistics, and others. By end-user, the market is divided into pharmaceutical companies, hospitals and clinics, medical device manufacturing companies, biotechnology companies, and others. On the basis of medium of transport, the market is classified into ground transportation, air cargo, and ocean freight. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The report analyzes the profiles of key players operating in the healthcare third-party logistics such as United Parcel Service of America, Inc., Cardinal Health, Kinesis Medical B.V., FedEx Supply Chain, Kuehne and Nagel, Expeditors International, CH Robinson Worldwide, Kerry Logistics Network Limited, SF Express, UPS Healthcare Logistics, Amerisource Burgen, Sinotrans, DHL Supply Chain, Freight logistics Solutions, DB Schenker, AGILITY, Barett Distribution, Nippon Express, XPO logistics. These players have adopted various strategies to increase their market penetration and strengthen their position in the healthcare third-party logistics market.
The expansion of global pharmaceutical trade is a significant driver increasing the demand for healthcare third-party logistics (3PL) services. As pharmaceutical companies extend their reach to international markets, the complexity of their supply chains grows substantially. Managing the shipment of medicines, vaccines, and biologics across borders requires specialized logistics solutions that ensure compliance with diverse regulatory requirements, temperature control, and product safety. Third-party logistics providers offer the expertise and infrastructure needed to navigate these challenges efficiently, including customs clearance, secure transportation, and real-time tracking. For instance, in March 2025, DHL Group acquired CRYOPDP from Cryoport, a supply chain logistics company, which represents a strategic move to strengthen its healthcare third-party logistics (3PL) capabilities. By enhancing specialized pharmaceutical logistics services, including temperature-controlled and secure distribution, DHL is expanding its role as a key 3PL provider in the life sciences and healthcare sector. This acquisition enables DHL to offer more comprehensive and reliable logistics solutions that meet the complex demands of healthcare products, thus supporting efficient supply chain management and ensuring the safe delivery of sensitive pharmaceuticals globally. In addition, the rise in cross-border e-commerce and direct-to-patient deliveries has heightened the need for reliable, scalable logistics services that can handle various distribution models worldwide. The globalization of pharmaceutical trade also demands agility to respond to varying market demands and supply disruptions. As a result, pharmaceutical companies increasingly rely on 3PL providers, thus driving robust growth in the healthcare third-party logistics sector.
The complex regulatory landscape significantly hampers the demand for healthcare third-party logistics (3PL) services. The healthcare industry is governed by stringent regulations related to the storage, transportation, and handling of sensitive products like pharmaceuticals, biologics, and medical devices. Compliance with diverse and constantly evolving regulations across different countries, including Good Distribution Practices (GDP), temperature control standards, and safety protocols, creates substantial challenges for 3PL providers. Navigating this regulatory complexity requires significant investments in specialized infrastructure, training, and technology, which can be costly and time-consuming. In addition, non-compliance risks include severe penalties, product recalls, and damage to reputation, making 3PL providers cautious in expanding operations. These regulatory hurdles often slow market entry and limit the flexibility of logistics providers, especially in emerging markets with less harmonized standards. Consequently, the complex regulatory environment restricts the growth potential of healthcare 3PL services despite the increasing demand for efficient and compliant supply chain solutions.
The increasing demand for end-to-end logistics solutions presents a lucrative opportunity for the healthcare third-party logistics (3PL) market. Healthcare companies are seeking comprehensive logistics providers that can manage the entire supply chain from procurement and storage to transportation and final delivery, ensuring seamless and efficient operations. End-to-end solutions help streamline complex processes, reduce costs, and improve visibility and traceability of sensitive products such as pharmaceuticals and biologics. With the rise of personalized medicine, temperature-sensitive products, and direct-to-patient distribution, healthcare providers require integrated logistics services that maintain product integrity and comply with stringent regulations. Third-party logistics providers offering these complete solutions can differentiate themselves by providing greater reliability, flexibility, and technology-driven transparency, which attracts more clients. Thus, rise in demand for end-to-end logistics solutions is expected to provide lucrative opportunities for the market.
The healthcare third-party logistics market is segmented on the basis of service type, end-user, medium of transport, and region. On the basis of service type, the market is segmented into transport service, warehouse and storage service, inventory management, clinical trial logistics, and others. By end-user, the market is divided into pharmaceutical companies, hospitals and clinics, medical device manufacturing companies, biotechnology companies, and others. On the basis of medium of transport, the market is classified into ground transportation, air cargo, and ocean freight. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
The report analyzes the profiles of key players operating in the healthcare third-party logistics such as United Parcel Service of America, Inc., Cardinal Health, Kinesis Medical B.V., FedEx Supply Chain, Kuehne and Nagel, Expeditors International, CH Robinson Worldwide, Kerry Logistics Network Limited, SF Express, UPS Healthcare Logistics, Amerisource Burgen, Sinotrans, DHL Supply Chain, Freight logistics Solutions, DB Schenker, AGILITY, Barett Distribution, Nippon Express, XPO logistics. These players have adopted various strategies to increase their market penetration and strengthen their position in the healthcare third-party logistics market.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the healthcare third-party logistics market analysis from 2024 to 2034 to identify the prevailing healthcare third-party logistics market opportunities.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the healthcare third-party logistics market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global healthcare third-party logistics market trends, key players, market segments, application areas, and market growth strategies.
Additional benefits you will get with this purchase are:
- Quarterly update with the purchase of an enterprise license.
- 5 additional company profiles of your choice, pre- or post-purchase, as a free update.
- Free version update with the purchase of an Enterprise User License.
- 16 hours of analyst support.
- 15% free customization (Equivalent to 3 working days of work, applicable once).
- Free data pack (Excel) with the purchase of an Enterprise User License.
- Free updated report if the report is 6-12 months old or older.
- 24-hour priority response.
- Free industry updates and white papers.
Further possible customization (additional cost and timeline):
- Industry life cycle assessment, by region
- New Product Development/ Product Matrix of Key Players
- Brands Share Analysis
Key Market Segments
By Service Type
- Transportation Service
- Warehousing and Storage Service
- Inventory Management Service
- Clinical Trial Logistics
- Others
By End User
- Pharmaceutical Companies
- Hospitals and Clinics
- Medical Device Manufacturing Companies
- Biotechnology Companies
- Others
By Medium of Transport
- Ground Transportation
- Air Cargo
- Ocean Freight
By Supply Chain
- Cold Chain Logistics
- Non Cold Chain Logistics
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- France
- Germany
- Italy
- Spain
- UK
- Russia
- Rest of Europe
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Malaysia
- Indonesia
- Rest of Asia-Pacific
- LAMEA
- Brazil
- South Africa,
- Saudi Arabia
- UAE
- Argentina
- Rest of LAMEA
Key Market Players
- SF Express
- Sinotrans
- DSV A/S
- Deutsche Post AG
- AmerisourceBergen Corporation
- Nippon Express Co., Ltd.
- Kuehne Nagel
- Cardinal Health
- C.H. Robinson Worldwide, Inc.
- FedEx
- GEODIS
- Barett Distribution
- Kinesis Medical B.V.
- United Parcel Service of America, Inc.
- XPO Logistics, Inc.
- KERRY LOGISTICS NETWORK LIMITED
- Expeditors International of Washington, Inc.
- Freight logistics Solutions
- BDP international
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET OVERVIEW
CHAPTER 4: HEALTHCARE THIRD-PARTY LOGISTICS MARKET, BY SERVICE TYPE
CHAPTER 5: HEALTHCARE THIRD-PARTY LOGISTICS MARKET, BY END USER
CHAPTER 6: HEALTHCARE THIRD-PARTY LOGISTICS MARKET, BY MEDIUM OF TRANSPORT
CHAPTER 7: HEALTHCARE THIRD-PARTY LOGISTICS MARKET, BY SUPPLY CHAIN
CHAPTER 8: HEALTHCARE THIRD-PARTY LOGISTICS MARKET, BY REGION
CHAPTER 9: COMPETITIVE LANDSCAPE
CHAPTER 10: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
- SF Express
- Sinotrans
- DSV A/S
- Deutsche Post AG
- AmerisourceBergen Corporation
- Nippon Express Co., Ltd.
- Kuehne Nagel
- Cardinal Health
- C.H. Robinson Worldwide, Inc.
- FedEx
- GEODIS
- Barett Distribution
- Kinesis Medical B.V.
- United Parcel Service of America, Inc.
- XPO Logistics, Inc.
- KERRY LOGISTICS NETWORK LIMITED
- Expeditors International of Washington, Inc.
- Freight logistics Solutions
- BDP international
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
